Did the FDA and CDC hide data that show the COVID-19 vaccines failing as early as January 2021?!
Take a look at the viral claim, and find out what the facts really are!
Claim : FDA + CDC Hid Data On Failing COVID-19 Vaccines!
People are sharing an article by The Epoch Times which claim or suggest that FDA and/or CDC hid data that show the COVID-19 vaccines failing as early as January 2021!
Here is an excerpt of The Epoch Times article. Feel free to skip to the next section for the facts:
Recommended : Died Suddenly : Anti-Vaccination Movie Lies Exposed!
No Evidence FDA + CDC Hid Data On Failing COVID-19 Vaccines!
In this article, I will go through some of their claims, and show you what the facts really are!
Fact #1 : Humetrix Study Was Commissioned By US DOD
First, let’s start by pointing out that the Humetrix study in question was commissioned by JAIC – the US Department of Defense Joint Artificial Intelligence Center. This was stated explicitly in an email by Humetrix President and CEO, Bettina Experton, to the FDA:
What this means is – the data belonged to the US Department of Defense, not Humetrix, the FDA, or the CDC.
Fact #2 : Humetrix Published Study Results In December 2022
It seems odd to accuse the US FDA and CDC of hiding data from the Humetrix study, when Humetrix publicly published its results in the open-access journal, Biology in December 2022.
The study is called “Enhanced Vaccine Effectiveness during the Delta Phase of the COVID-19 Pandemic in the Medicare Population Supports a Multilayered Prevention Approach“.
Fact #3 : No Evidence CDC / FDA Hid Humetrix Study
There is no evidence that the FDA or CDC hid the Humetrix study or its data. The Epoch Times article did not offer any evidence, beyond pointing out that the Humetrix analysis was “not presented” during a meeting to approve the booster dose.
Ironically, the same article pointed out that the CDC presented data from its COVID-NET data that showed falling vaccine effectiveness in the elderly against the Delta variant. So why should the CDC / FDA try to “hide” the Humetrix data?
Is it not possible that the CDC preferred to rely on its own data? Or perhaps, the CDC decided that the COVID-NET data was compelling enough, it did not need to supplement with the similar data from the Humetrix study?
Fact #4 : Vaccines Were Not Meant To Prevent Infection
While many anti-vaccine activists harp on the fact that COVID-19 vaccines fail to prevent transmission or breakthrough infections, the truth is – the vaccines were designed to prevent severe disease and deaths from COVID-19.
It would be nice if they can significantly block transmission, or breakthrough infections, but those were never the endpoints in any COVID-19 vaccine trial. If you look back at the vaccine trial results, they were only looking at protection against “symptomatic infection“, “severe disease“, and “death“.
|COVID-19 Vaccine||Protection Against|
|Gamaleya Sputnik V||91.6%||100%||100%|
|AstraZeneca AZD1222||62% ~ 90%||100%||100%|
|Sinopharm BBIBP-CorV||79% ~ 86%||90%||100%|
|J&J Janssen COVID-19||66.0%||85%||100%|
Therefore, their constant harping of the “inability” or “failure” of COVID-19 vaccines to block transmission, or completely prevent infections, is a red herring. That was never the goal of these vaccines.
Even if you are fully-vaccinated, you can continue to get breakthrough infections, and that’s fine. The key thing is vaccines help to prevent severe disease and death from COVID-19 infections.
Fact #5 : Humetrix Study Looked At Delta Variant
It is also important to note that the Humerix study looked at the Delta variant, as its title stated clearly – Effectiveness of mRNA COVID-19 Vaccines Against the Delta Variant Among 6M Medicare Beneficiaries 65 Years and Older.
The original COVID-19 vaccines were designed to target the original (ancestral) SARS-CoVo-2 virus. The Delta variant did not exist at that time.
The Humerix study did not address or disparage the effectiveness of the vaccines against the original SARS-CoV-2 virus that they were originally meant to target. It was looking to see if the original mRNA vaccine could also protect against the Delta variant.
Fact #5 : Reduced Protection vs. Delta Variant Spurs Need For Booster Dose
The Humerix study, at that time, was presented to the FDA for its use in the consideration whether to approve the booster dose looked at the effectiveness of the Pfizer and Moderna mRNA vaccines against the new (at that time) Delta variant.
Because it showed reduced vaccine effectiveness against infections and hospitalisations, that would actually support the approval of a booster dose to boost protection against COVID-19.
If the Humetrix study actually showed the original mRNA vaccines’ strong protection against the Delta variant, the FDA and/or CDC might not feel the need to approve or support a booster dose at that time.
This was actually mentioned in the Executive Summary of the Humetrix presentation on Page 2:
Please help us FIGHT FAKE NEWS by sharing this fact check article out, and please SUPPORT our work!
Don’t forget to protect yourself, and your family, by vaccinating against COVID-19!
- Is There An Ebola Outbreak At Burning Man 2023?!
- Is BlackRock The Largest Shareholder Of TEPCO?!
- Did Singapore Detect More Radioactive Food From Japan?!
- Do You Need UK ETA (Electronic Travel Authorisation)?
- EU + Japan Have Secret Agreement To Re-Export Seafood?!
If you like our work, please support us by visiting our sponsors, or donating to our fund. Thank you!